Organigram Global (OGI) Total Non-Current Liabilities (2019 - 2026)
Organigram Global (OGI) posted quarterly Total Non-Current Liabilities of $107.9 million for Q1 2026, down 2.85% quarter-over-quarter from $111.1 million in Q4 2025.
Organigram Global (OGI) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Total Non-Current Liabilities for 6 consecutive years, with $107.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $107.9 million; the TTM figure through Mar 2026 stood at $107.9 million (changed N/A YoY), while the FY2025 annual figure was $111.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities slipped to $107.9 million in Q1 2026 per OGI's latest filing, from $111.1 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $149.0 million in Q3 2025 and bottomed at $72.2 million in Q3 2024.
- Historically, Total Non-Current Liabilities has averaged $110.1 million across 3 years, with a median of $109.5 million in 2025.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 106.3% in 2025 and fell as far as 106.3% in 2025.
- Organigram Global's Total Non-Current Liabilities stood at $72.2 million in 2024, then soared by 53.88% to $111.1 million in 2025, then retreated by 2.85% to $107.9 million in 2026.
- Business Quant data shows OGI's Total Non-Current Liabilities at $107.9 million in Q1 2026, $111.1 million in Q4 2025, and $149.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 334.00 Mn |
| 10 | Organigram Global | 150.66 Mn | 150.54 Mn | 28.97 Mn | 107.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.95 Mn |
| Dec 31, 2025 | 111.11 Mn |
| Sep 30, 2025 | 148.96 Mn |
| Sep 30, 2024 | 72.21 Mn |
| Nov 30, 2021 | -8.22 Mn |
| Aug 31, 2021 | 49.51 Mn |
| May 31, 2021 | -9.20 Mn |
| Feb 28, 2021 | 120.87 Mn |
| Nov 30, 2020 | 150.00 Mn |
| Aug 31, 2020 | 98.06 Mn |
| May 31, 2020 | 78.98 Mn |
| Feb 29, 2020 | 121.85 Mn |
| Aug 31, 2019 | 75.94 Mn |